| pubmed-article:7587853 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C0021641 | lld:lifeskim |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C0017725 | lld:lifeskim |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C0441994 | lld:lifeskim |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C0439784 | lld:lifeskim |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C0917707 | lld:lifeskim |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:7587853 | lifeskim:mentions | umls-concept:C1514863 | lld:lifeskim |
| pubmed-article:7587853 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:7587853 | pubmed:dateCreated | 1995-11-30 | lld:pubmed |
| pubmed-article:7587853 | pubmed:abstractText | To determine whether the reproducibility of the first-phase insulin response (FPIR) measured during an intravenous glucose tolerance test is improved by the use of a lower glucose dose or retrograde sampling from an arterialized hand vein. | lld:pubmed |
| pubmed-article:7587853 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7587853 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7587853 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7587853 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7587853 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7587853 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7587853 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7587853 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:7587853 | pubmed:issn | 0149-5992 | lld:pubmed |
| pubmed-article:7587853 | pubmed:author | pubmed-author:HarrisonL CLC | lld:pubmed |
| pubmed-article:7587853 | pubmed:author | pubmed-author:AlfordF PFP | lld:pubmed |
| pubmed-article:7587853 | pubmed:author | pubmed-author:ColmanP GPG | lld:pubmed |
| pubmed-article:7587853 | pubmed:author | pubmed-author:McNairP DPD | lld:pubmed |
| pubmed-article:7587853 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7587853 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:7587853 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7587853 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7587853 | pubmed:pagination | 1168-73 | lld:pubmed |
| pubmed-article:7587853 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:meshHeading | pubmed-meshheading:7587853-... | lld:pubmed |
| pubmed-article:7587853 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7587853 | pubmed:articleTitle | Reproducibility of the first-phase insulin response to intravenous glucose is not improved by retrograde cannulation and arterialization or the use of a lower glucose dose. | lld:pubmed |
| pubmed-article:7587853 | pubmed:affiliation | Royal Melbourne Hospital, Parkville, Victoria, Australia. | lld:pubmed |
| pubmed-article:7587853 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7587853 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:7587853 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
